We propose to extend our observations on our large cohort of zinc treated patients with Wilson's Disease. A substantial number have been followed for ten years or longer on zinc therapy, and an even larger number for eight years or longer. Data will continue to be collected on a very large series of copper and clinical variables. Our patient groups include maintenance therapy, treatment of presymptomatic patients from the beginning, pregnant patients, and pediatric patients.
Showing the most recent 10 out of 1380 publications